Methods and compositions for treating virus-associated inflammation Grant US-11840565-B2 United States of America 12 Dec 2023
Methods and compositions for sustained immunotherapy Grant US-11338024-B2 United States of America 24 May 2022
Methods and compositions for treating virus-associated inflammation Grant US-11174307-B2 United States of America 16 Nov 2021
Compositions and methods for the prevention and treatment of cancer Grant US-11000596-B2 United States of America 11 May 2021
Methods and compositions for treating inflammation Grant US-10988516-B2 United States of America 27 Apr 2021
Methods for treating lung inflammation with an anti-ASC antibody Grant US-10961306-B2 United States of America 30 Mar 2021
Methods and compositions for treating multiple sclerosis and related disorders Grant US-10905773-B2 United States of America 02 Feb 2021
Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein… Grant US-10759838-B2 United States of America 01 Sep 2020
METHODS OF TREATING GLIOBLASTOMA MULTIFORME USING IBUDILAST Application EP-3558301-A4 European Patent Office 29 Jul 2020
Methods and compositions for treating multiple sclerosis Grant US-10703811-B2 United States of America 07 Jul 2020
NDP-MSH for treatment of inflammatory and/or neurodegenerative disorders of the central… Grant US-10610573-B2 United States of America 07 Apr 2020
Nanoparticle compositions for sustained therapy Grant US-10485882-B2 United States of America 26 Nov 2019
Myelin oligodendrocyte glycoprotein (MOG) peptide Grant US-10377800-B2 United States of America 13 Aug 2019
Compositions and methods for the prevention and treatment of cancer Grant US-10172955-B2 United States of America 08 Jan 2019
TREATMENT OF NEUROINFLAMMATORY DISEASE Application US-20180346577-A1 United States of America 06 Dec 2018
Methods and compositions for sustained immunotherapy Grant US-10124045-B2 United States of America 13 Nov 2018
Methods and compositions for treating multiple sclerosis and related disorders Grant US-10080808-B2 United States of America 25 Sep 2018
Nicotinic attenuation of CNS inflammation and autoimmunity Grant US-10080747-B2 United States of America 25 Sep 2018
Local engineering of the lymph node environment to promote immune tolerance Grant US-10071145-B2 United States of America 11 Sep 2018
Neuropeptide Y treatment of autoimmune disease Grant US-9956268-B2 United States of America 01 May 2018
MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN… Application US-20180105566-A1 United States of America 19 Apr 2018
Myelin oligodendrocyte glycoprotein peptides Grant US-9862751-B2 United States of America 09 Jan 2018
Local engineering of the lymph node environment to promote immune tolerance Grant US-9610349-B2 United States of America 04 Apr 2017
Methods and compositions for treating multiple sclerosis and related disorders Grant US-9603948-B2 United States of America 28 Mar 2017
Nicotinic attenuation of CNS inflammation and autoimmunity Grant US-9566273-B2 United States of America 14 Feb 2017
TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FLUPIRTINE Application US-20170007596-A1 United States of America 12 Jan 2017
Compositions and methods for treating multiple sclerosis Grant US-9518104-B2 United States of America 13 Dec 2016
Compositions and methods for the prevention and treatment of cancer Grant US-9511151-B2 United States of America 06 Dec 2016
Compositions and methods for treatment of taupathy Grant US-9492404-B2 United States of America 15 Nov 2016
Methods for Treating and Preventing Multiple Sclerosis Application US-20160237168-A1 United States of America 18 Aug 2016
NDP-MSH FOR TREATMENT OF INFLAMMATORY AND/OR NEURODEGENERATIVE DISORDERS OF THE CENTRAL… Application US-20160158322-A1 United States of America 09 Jun 2016
Biomarkers used to detect and monitor neurological autoimmune diseases Grant US-9304123-B2 United States of America 05 Apr 2016
Method for the treatment of multiple sclerosis Grant US-9132138-B2 United States of America 15 Sep 2015
COMBINATION THERAPIES AND USES FOR TREATMENT OF DEMYELINATING DISORDERS Application US-20150238602-A1 United States of America 27 Aug 2015
TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FLUPIRTINE Application US-20150037318-A1 United States of America 05 Feb 2015
Compositions and Methods for Treating Multiple Sclerosis Application US-20140378387-A1 United States of America 25 Dec 2014
NICOTINIC ATTENUATION OF CNS INFLAMMATION AND AUTOIMMUNITY Application US-20140364463-A1 United States of America 11 Dec 2014
EXTRACT AND PEPTIDES DERIVED FROM ORYZA SATIVA JAPONICA GROUP AND USES THEREOF Application US-20140256645-A1 United States of America 11 Sep 2014
METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS Application US-20140105980-A1 United States of America 17 Apr 2014
METHOD FOR SUPPRESSING AN IMMUNE RESPONSE Application US-20140072593-A1 United States of America 13 Mar 2014
Method for the Treatment of Multiple Sclerosis Application US-20140056848-A1 United States of America 27 Feb 2014
BIOMARKERS USED TO DETECT AND MONITOR NEUROLOGICAL AUTOIMMUNE DISEASES Application US-20140045197-A1 United States of America 13 Feb 2014
Neuroprotection in Demyelinating Diseases Application US-20130287732-A1 United States of America 31 Oct 2013
Neuropeptide Y Treatment of Autoimmune Disease Application US-20130259901-A1 United States of America 03 Oct 2013
ANG-2 INHIBITION TO TREAT MULTIPLE SCLEROSIS Application US-20110158978-A1 United States of America 30 Jun 2011